Method for removing pyrogens from plasma and blood for treatment of septic shock

In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C 10 -C 24 alky...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Amoureux, Marie-Claude, Hegyi, Edit, Grandics, Peter, Szathmary, Susan
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Amoureux, Marie-Claude
Hegyi, Edit
Grandics, Peter
Szathmary, Susan
description In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C 10 -C 24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form. Preferably, the halogenated quinolone moiety is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. The invention also includes resins useful in methods according to the present invention and cartridges incorporating such resins.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20040014022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20040014022</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200400140223</originalsourceid><addsrcrecordid>eNqVyzEOwjAMQNEsDAi4g1cGpBB6AwRiQWJgr0zqtBFJHMUGidvD0Asw_eX9pbldSSceIHCDRpnfsYxQP41HKgKhcYaaUDIClgEeiWerjVAzFQUOIFQ1epCJ_XNtFgGT0GbuymzPp_vxsntJRf0N0mOtKXrUyEV6Z21n7b6zzh3-sV-maD4w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method for removing pyrogens from plasma and blood for treatment of septic shock</title><source>USPTO Published Applications</source><creator>Amoureux, Marie-Claude ; Hegyi, Edit ; Grandics, Peter ; Szathmary, Susan</creator><creatorcontrib>Amoureux, Marie-Claude ; Hegyi, Edit ; Grandics, Peter ; Szathmary, Susan</creatorcontrib><description>In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C 10 -C 24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form. Preferably, the halogenated quinolone moiety is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. The invention also includes resins useful in methods according to the present invention and cartridges incorporating such resins.</description><language>eng</language><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20040014022$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64032</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10198774$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Amoureux, Marie-Claude</creatorcontrib><creatorcontrib>Hegyi, Edit</creatorcontrib><creatorcontrib>Grandics, Peter</creatorcontrib><creatorcontrib>Szathmary, Susan</creatorcontrib><title>Method for removing pyrogens from plasma and blood for treatment of septic shock</title><description>In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C 10 -C 24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form. Preferably, the halogenated quinolone moiety is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. The invention also includes resins useful in methods according to the present invention and cartridges incorporating such resins.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNqVyzEOwjAMQNEsDAi4g1cGpBB6AwRiQWJgr0zqtBFJHMUGidvD0Asw_eX9pbldSSceIHCDRpnfsYxQP41HKgKhcYaaUDIClgEeiWerjVAzFQUOIFQ1epCJ_XNtFgGT0GbuymzPp_vxsntJRf0N0mOtKXrUyEV6Z21n7b6zzh3-sV-maD4w</recordid><startdate>20040122</startdate><enddate>20040122</enddate><creator>Amoureux, Marie-Claude</creator><creator>Hegyi, Edit</creator><creator>Grandics, Peter</creator><creator>Szathmary, Susan</creator><scope>EFI</scope></search><sort><creationdate>20040122</creationdate><title>Method for removing pyrogens from plasma and blood for treatment of septic shock</title><author>Amoureux, Marie-Claude ; Hegyi, Edit ; Grandics, Peter ; Szathmary, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200400140223</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Amoureux, Marie-Claude</creatorcontrib><creatorcontrib>Hegyi, Edit</creatorcontrib><creatorcontrib>Grandics, Peter</creatorcontrib><creatorcontrib>Szathmary, Susan</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Amoureux, Marie-Claude</au><au>Hegyi, Edit</au><au>Grandics, Peter</au><au>Szathmary, Susan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method for removing pyrogens from plasma and blood for treatment of septic shock</title><date>2004-01-22</date><risdate>2004</risdate><abstract>In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C 10 -C 24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form. Preferably, the halogenated quinolone moiety is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. The invention also includes resins useful in methods according to the present invention and cartridges incorporating such resins.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_20040014022
source USPTO Published Applications
title Method for removing pyrogens from plasma and blood for treatment of septic shock
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A14%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Amoureux,%20Marie-Claude&rft.date=2004-01-22&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20040014022%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true